Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kuwait Life Sciences Company

Founders Qais Marafie

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 3
Rounds per year 0.36
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees 1

Areas of investment

  • Medical Device
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
Summary

Kuwait Life Sciences Company is the famous Corporate Investor, which was founded in 2010. The leading representative office of defined Corporate Investor is situated in the Safat. The fund was located in Asia if to be more exact in Kuwait.

The fund was created by Qais Marafie.

Comparing to the other companies, this Kuwait Life Sciences Company performs on 4 percentage points more the average number of lead investments. The high activity for fund was in 2013. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.

Among the most popular fund investment industries, there are Biotechnology, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Arab Emirates. Among the various public portfolio startups of the fund, we may underline Quanta, SuperSonic Imagine, NewBridge Pharmaceuticals Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Kuwait Life Sciences Company, startups are often financed by NBGI Ventures, Omnes Capital, Bioam Gestion. The meaningful sponsors for the fund in investment in the same round are Wellington Partners, NBGI Ventures, Burrill & Company. In the next rounds fund is usually obtained by btov Partners, Wellington Partners, Seroba Life Sciences.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kuwait Life Sciences Company:
Typical Co-investors
Kuwait Life Sciences Company is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kuwait Life Sciences Company:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
7 Global Capital California, San Francisco, United States
ALZIS -
Arohi Asset Management Central, Central Region, Singapore
China Huarong China, Shanghai
Construct Venture -
Eight Innovate -
Galena Asset Management England, London, United Kingdom
George Kaiser Family Foundation Oklahoma, Tulsa, United States
Grubstakes Seattle, United States, Washington
Morton Cohn Investments Houston, Texas, United States
National Institute of Diabetes and Digestive and Kidney Diseases -
Nemetschek Bayern, Germany, München
SFU Seeders British Columbia, Canada, Vancouver
Singer Capital Beijing, Beijing, China
Start Garden Grand Rapids, Michigan, United States
Technology Innovation Agency Gauteng, Pretoria, South Africa
Virtu Financial New York, New York, United States
Wesley Clover Canada, Ontario, Ottawa
WinWin Ventures Andhra Pradesh, East Godavari, India
ZGC Shiner Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Quanta

Clinical Trials
Health Care
Medical
Medical Device
$36M03 Nov 2014 England

Biotechnology
Medical Device
Pharmaceutical
$48M29 May 2013 Dubai, United Arab Emirates

Biotechnology
Medical Device
Pharmaceutical
$12M20 Sep 2010 Dubai, United Arab Emirates

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kuwait Life Sciences Company?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 32M
Rounds per year 0.36
Peak activity year 2013
Lead investments 1
Follow on index 0.25
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Quanta

Clinical Trials
Health Care
Medical
Medical Device
$36M03 Nov 2014 England

Biotechnology
Medical Device
Pharmaceutical
$48M29 May 2013 Dubai, United Arab Emirates

Biotechnology
Medical Device
Pharmaceutical
$12M20 Sep 2010 Dubai, United Arab Emirates
Crunchbase icon

Content report

The following text will be sent to our editors: